Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapy

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer death worldwide with a minority of patients being diagnosed early enough for curative-intent interventions. We report the first use of preoperative cabozantinib plus nivolumab to successfully downstage what presented as unresectabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Won Jin, Sharma, Gaurav, Zhu, Qingfeng, Stein-O'Brien, Genevieve, Durham, Jennifer, Anders, Robert, Popovic, Aleksandra, Mo, Guanglan, Kamel, Ihab, Weiss, Matthew, Jaffee, Elizabeth, Fertig, Elana J, Yarchoan, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682468/
https://www.ncbi.nlm.nih.gov/pubmed/33219090
http://dx.doi.org/10.1136/jitc-2020-000932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682468/
https://www.ncbi.nlm.nih.gov/pubmed/33219090
http://dx.doi.org/10.1136/jitc-2020-000932

Ejemplares similares